These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3016677)

  • 1. Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells.
    Calvo JR; Molinero P; Jimenez J; Goberna R; Guerrero JM
    Peptides; 1986; 7(2):177-81. PubMed ID: 3016677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for vasoactive intestinal peptide on isolated epithelial cells of rat ventral prostate.
    Prieto JC; Carmena MJ
    Biochim Biophys Acta; 1983 Dec; 763(4):408-13. PubMed ID: 6317051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of vasoactive intestinal polypeptide (VIP) by human blood monocytes: demonstration of specific binding sites.
    Wiik P; Opstad PK; Bøyum A
    Regul Pept; 1985 Oct; 12(2):145-53. PubMed ID: 2999883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of vasoactive intestinal peptide with human blood mononuclear cells.
    Guerrero JM; Prieto JC; Elorza FL; Ramirez R; Goberna R
    Mol Cell Endocrinol; 1981 Feb; 21(2):151-60. PubMed ID: 6260561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
    Nguyen TT; Krco CJ; Gores A; Go VL
    Immunol Invest; 1987 Nov; 16(7):555-77. PubMed ID: 2832322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
    Prieto JC; Guerrero JM; de Miguel C; Goberna R
    Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages.
    Segura JJ; Guerrero JM; Goberna R; Calvo JR
    Regul Pept; 1991 Apr; 33(2):133-43. PubMed ID: 1652777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H; Shima K; Said SI
    Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VIP binding to epithelial cell membranes of rat ventral prostate: effect of guanine nucleotides.
    Carmena MJ; Prieto JC
    Gen Pharmacol; 1985; 16(5):495-500. PubMed ID: 2996970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of binding sites for beta-adrenergic agonists and vasoactive intestinal peptide in the rat harderian gland.
    Guerrero JM; Osuna C; Molinero P; Caraballo MI; Harmouch A; Pozo D; Rafii-el-Idrissi M; Garcia-Macias JF; Calvo JR
    Microsc Res Tech; 1996 Jun; 34(2):139-43. PubMed ID: 8722708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and localization of vasoactive intestinal peptide receptors in the rat lung.
    Leroux P; Vaudry H; Fournier A; St-Pierre S; Pelletier G
    Endocrinology; 1984 May; 114(5):1506-12. PubMed ID: 6325122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A; Rousset M; Laburthe M
    Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
    Broyart JP; Dupont C; Laburthe M; Rosselin G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
    Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
    Guijarro LG; Rodriguez-Pena MS; Prieto JC
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretin binding sites coupled with adenylate cyclase in rat fundic membranes.
    Gespach C; Bataille D; Vauclin N; Rosselin G; Moroder L; Wünsch E
    Peptides; 1981; 2 Suppl 2():247-51. PubMed ID: 6283494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes.
    Danek A; O'Dorisio MS; O'Dorisio TM; George JM
    J Immunol; 1983 Sep; 131(3):1173-7. PubMed ID: 6309960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP.
    Lopez-Gonzalez MA; Calvo JR; Osuna C; Guerrero JM
    J Pineal Res; 1992 Apr; 12(3):97-104. PubMed ID: 1324307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.